Hepatology
The Hepatology Specialty Group is one of 23
Specialty Groups which provide national networks
of topic-specific expertise. These groups are key to
the success of the CCRN. They work at both national
and local levels to ensure the successful delivery of
research within their specialties. This means ensuring
that studies are delivered to target and on time.
The remit of the Hepatology Specialty Group is to support a national portfolio of structured research studies related to the pathogenesis, diagnosis, treatment and prevention of liver disease. The Hepatology Specialty Group’s portfolio includes:
- Acute and chronic liver disease including liver failure
- Viral hepatitis
- Liver fibrosis and cirrhosis
- Studies of normal and abnormal liver metabolism
- Genetic studies including pharmacogenetics
- Biomarkers
- Hepatotoxicity
| 
|
The Hepatology Specialty Group takes the lead on studies led by hepatologists, or where hepatologists have major input. The Hepatology Specialty Group works alongside the NIHR Cancer Research Network to support studies of cancers of the liver and biliary tract, and with the Surgery Specialty Group on studies of surgical interventions of the liver and biliary tract.
What we do
How we work with the life-sciences industry
How to get involved
Contact us
